IVD Quality Controls Market – Top Players and Growth Strategies
According to research report the global IVD quality control market is expected to reach USD 1.04 billion by 2022, at a CAGR of 3.5% from 2017 to 2022. The global IVD quality controls market is oligopolistic in nature with very few players accounting for a major share of the market. Bio-Rad Laboratories, Inc. (U.S.), Randox Laboratories (U.K.), and Thermo Fisher Scientific, Inc. (U.S.) are the major players in this market. A majority of the leading players in this market are based in developed countries across North America and Europe. Read more : https://www.marketsandmarkets.com/PressReleases/in-vitro-diagnostics-quality-controls.asp In 2016, Bio-Rad Laboratories held the leading position in the IVD quality controls market. This can be attributed to its highly diversified quality controls portfolio, which includes controls for immunoassay, therapeutic drug monitoring, serum chemistry, and urine chemistry; urinalysis controls; cardiac assessment quality controls; immunology/protein ...